Lenacapavir Tablet, Cabotegravir, Lenacapavir, Teropavimab, Zinlirvimab, Rilpivirine, Cab, Rpv, Len
Hiv Infections
Phase III
Recruiting
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
Jun 26, 2026
Gs-2426
Advanced Solid Tumors
Phase I
Recruiting
Study of GS-2426 in Participants With Advanced Solid Tumors
May 15, 2026
―
Paclitaxel, Ramucirumab, Nivolumab, Denikitug
Esophageal Adenocarcinoma, Gastric Adenocarcinoma, Her2-Negative, Gastroesophageal Junction
Phase II
Recruiting
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas
Apr 17, 2026
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Gilead Sciences (GILD) have in its pipeline
GILD is currently developing the following drugs: Lenacapavir Injection, Lenacapavir Tablet, B/F/Taf, Gs-3242 Tablet, Gs-3242 Injection, Len, Lenacapavir Tablet, Cabotegravir, Lenacapavir, Teropavimab, Zinlirvimab, Rilpivirine, Cab, Rpv, Len, Lenacapavir Tablet, Lenacapavir, Teropavimab, Zinlirvimab, Sbr, Len. These drug candidates are in various stages of clinical development as the company works toward FDA approval.